medroxyprogesterone acetate has been researched along with Ductal Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bottino, MC; Cerliani, JP; Fabris, VT; Giulianelli, S; Helguero, LA; Lamb, CA; Lanari, C; Molinolo, A; Soldati, R; Wargon, V | 1 |
1 review(s) available for medroxyprogesterone acetate and Ductal Carcinoma
| Article | Year |
|---|---|
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma, Ductal; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone | 2009 |